IP
NMTR

Intellectus Partners’s 9 Meters Biopharma NMTR Stock Holding History

Intellectus Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5
Closed -$1K – 555
2018
Q3 		$1K Hold
5
– – ﹤0.01% 567
2018
Q2 		$2K Hold
5
– – ﹤0.01% 569
2018
Q1 		$3K Buy
+5
New +$973 ﹤0.01% 557

Other funds holding NMTR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $109B AUM 42.89% 1-Year Est. Return

Intellectus Partners's NMTR Position: Q4 2018 in Review

Intellectus Partners sold out of 9 Meters Biopharma (NMTR) in Q4 2018, closing a stake of 5 shares — an estimated $1K sold.

Intellectus Partners first reported a position in NMTR in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2018. 39 funds tracked by Wall St. Rank hold NMTR as of Q4 2018.

  • Intellectus Partners reported no remaining 9 Meters Biopharma position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 5 9 Meters Biopharma shares in Q4 2018, an estimated $1K.
  • Intellectus Partners first reported a position in 9 Meters Biopharma in Q1 2018 and held it in 3 quarters.
  • Intellectus Partners's 9 Meters Biopharma position peaked at $3K in Q1 2018.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.